Novavax, Inc. (NASDAQ:NVAX) last session’s volum
Post# of 23080
(Total Views: 272)
Posted On: 07/21/2017 7:59:11 AM
Novavax, Inc. (NASDAQ:NVAX) last session’s volume of 11.29 million shares was higher than its average volume of 6.27 million shares. The stock, after opening at $1.42, hit $1.51 through the close by scoring 6.34%.
Novavax, Inc. (NVAX) Analyst Opinion
Novavax, Inc. has a consensus hold rating from 6 Wall Street analysts, and the number of shares currently sold short amount to at least 20.43% of shares outstanding. The stock spiked 33.63% last month and is up 19.84 this year. Wall Street is only getting neutral on the stock, with 0 of analysts who cover NVAX having a buy-equivalent rating. Analysts have placed a $3.48 price target on Novavax, Inc., suggesting a 130.46% gain from recent close. It’s currently trading about -82.21% below its 52-week high.
Novavax, Inc. Earnings Surprise
Novavax, Inc. (NVAX) surprised the stock market in its last reported earnings when it earned -$0.16 a piece versus the consensus-estimated -$0.17. Its revenue totaled $6.17 million up 14.26% from the previous quarter.
Novavax, Inc. (NASDAQ:NVAX) Intraday View
This stock (NVAX) is ahead of its 52-week low with 106.85%. Its last month’s stock price volatility remained 13.46% which for the week stands at 7.31%. The share price has moved forward from its 20 days moving average, trading at a distance of 26.57% and stays 38.25% away from its 50 days moving average. Over the last five days, shares have managed 29.06% gains and now is up 19.15% since hitting its 200-day moving average of $1.18. Novavax, Inc. (NVAX) has made its way to a 12-month decline of -79.68%.
Novavax, Inc. (NVAX) Analyst Opinion
Novavax, Inc. has a consensus hold rating from 6 Wall Street analysts, and the number of shares currently sold short amount to at least 20.43% of shares outstanding. The stock spiked 33.63% last month and is up 19.84 this year. Wall Street is only getting neutral on the stock, with 0 of analysts who cover NVAX having a buy-equivalent rating. Analysts have placed a $3.48 price target on Novavax, Inc., suggesting a 130.46% gain from recent close. It’s currently trading about -82.21% below its 52-week high.
Novavax, Inc. Earnings Surprise
Novavax, Inc. (NVAX) surprised the stock market in its last reported earnings when it earned -$0.16 a piece versus the consensus-estimated -$0.17. Its revenue totaled $6.17 million up 14.26% from the previous quarter.
Novavax, Inc. (NASDAQ:NVAX) Intraday View
This stock (NVAX) is ahead of its 52-week low with 106.85%. Its last month’s stock price volatility remained 13.46% which for the week stands at 7.31%. The share price has moved forward from its 20 days moving average, trading at a distance of 26.57% and stays 38.25% away from its 50 days moving average. Over the last five days, shares have managed 29.06% gains and now is up 19.15% since hitting its 200-day moving average of $1.18. Novavax, Inc. (NVAX) has made its way to a 12-month decline of -79.68%.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'